BNC Wealth Management’s AbbVie ABBV Stock Holding History

BNC Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Sell	1,072 -16	-1%	-$3.55K	0.06%	96
2025 Q4	$249K	Hold	1,088	–	–	0.06%	89
2025 Q3	$252K	Sell	1,088 -2	-0.2%	-$407	0.06%	89
2025 Q2	$202K	Hold	1,090	–	–	0.06%	96
2025 Q1	$228K	Buy	+1,090	New	+$212K	0.08%	86
2024 Q4	–	Sell	-1,101	Closed	-$217K	–	97
2024 Q3	$217K	Buy	+1,101	New	+$205K	0.08%	86
2024 Q2	–	Sell	-1,126	Closed	-$205K	–	100
2024 Q1	$205K	Buy	+1,126	New	+$194K	0.09%	97
2023 Q2	–	Sell	-1,261	Closed	-$201K	–	100
2023 Q1	$201K	Buy	1,261 +5	+0.4%	+$764	0.11%	103
2022 Q4	$203K	Buy	+1,256	New	+$193K	0.12%	100
2020 Q4	–	Sell	-823	Closed	-$72K	–	97
2020 Q3	$72K	Buy	+823	New	+$77.5K	0.05%	139

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BNC Wealth Management's ABBV Position: Q1 2026 in Review

BNC Wealth Management reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $3.55K and leaving 1,072 shares worth $233K. The position accounts for 0.06% of the portfolio, ranked #96.

BNC Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 10 quarters since. The position peaked at $252K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

BNC Wealth Management held 1,072 shares of AbbVie worth $233K as of Q1 2026.
BNC Wealth Management sold 16 AbbVie shares in Q1 2026, an estimated $3.55K.
AbbVie made up 0.06% of BNC Wealth Management's portfolio in Q1 2026, its #96 holding.
BNC Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 10 quarters since.
BNC Wealth Management's AbbVie position peaked at $252K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BNC Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.